Embecta Corp. (EMBC) Price Target Analysis
Wall Street analyst price targets, ratings consensus & upside potential · Updated May 1, 2026
Current Price
$3.60
Price Target
$12.00
Target Range
$12.00 — $12.00
Analyst Rating
Sell
Forward P/E1.3x
Trailing P/E2.2x
Forward PEG—
Implied Growth+48.2%
Median Target$12.00
Analyst Spread0.0%
Price Forecast (1 Year)
Last 12 months price action with 12-month analyst target path
Bear Case
$12
+233.3%
Consensus
$12
+233.3%
Bull Case
$12
+233.3%
EMBC Price Target Analysis
Updated May 8, 2026As of May 8, 2026, Embecta Corp. (EMBC) has a Wall Street consensus price target of $12.00, based on estimates from 4 covering analysts. With the stock currently trading at $3.60, this represents a potential upside of +233.3%. The company has a market capitalization of $214M.
Analyst price targets range from a low of $12.00 to a high of $12.00, representing a 0% spread in expectations. The median target of $12.00 aligns closely with the consensus average. The tight target dispersion indicates high conviction among analysts.
The current analyst consensus rating is Sell, with 1 analysts rating the stock as a Buy or Strong Buy,1 rating it Hold, and 2 rating it Sell or Strong Sell. The bearish sentiment suggests caution about the stock at current levels.
From a valuation perspective, EMBC trades at a trailing P/E of 2.2x and forward P/E of 1.3x. Analysts expect EPS to grow +48.2% over the next year.
Investment Context: Price targets represent analyst expectations for the next 12 months and should be considered alongside your own research. Targets are based on analysts' assumptions about earnings growth, margins, and market conditions which may change. For sector-specific context, view other Healthcare stocks.
Analyst Sentiment Comparison
Industry Peer AnalysisAvg Peer Upside+42.7%
Avg Forward P/E17.2x
Peers with Coverage9 / 10
| Company | Market Cap | Price | Target | Upside | Rating | Fwd P/E | Analysts |
|---|---|---|---|---|---|---|---|
 UTMDUtah Medical Products, Inc. | $210M | $65.40 | — | — | — | 10.4x | — |
 LFUSLittelfuse, Inc. | $11.1B | $441.58 | $400.00 | -9.4% | Buy | 33.8x | 11 |
 NVCRNovoCure Limited | $1.9B | $16.83 | $33.50 | +99.0% | Buy | — | 15 |
 ITGRInteger Holdings Corporation | $3.0B | $87.92 | $98.00 | +11.5% | Buy | 13.5x | 14 |
 MMSIMerit Medical Systems, Inc. | $3.7B | $62.33 | $95.00 | +52.4% | Buy | 15.5x | 13 |
 BDXBecton, Dickinson and Company | $55.5B | $153.26 | $172.85 | +12.8% | Buy | 12.3x | 33 |
 NVONovo Nordisk A/S | $203.5B | $45.79 | $47.00 | +2.6% | Buy | 2.1x | 39 |
 DXCMDexCom, Inc. | $23.5B | $60.91 | $80.88 | +32.8% | Buy | 24.5x | 52 |
 PODDInsulet Corporation | $11.3B | $160.40 | $339.00 | +111.3% | Buy | 25.2x | 50 |
 TNDMTandem Diabetes Care, Inc. | $1.3B | $18.47 | $31.62 | +71.2% | Buy | — | 39 |
Upside Potential Comparison
PODDNVCRTNDMMMSIDXCMBDXITGRNVOSee EMBC's True Return
Price is only half the story. See total return with reinvested dividends.
Launch CalculatorIs EMBC Undervalued?
DCF intrinsic value, peer multiples, and analyst estimates — see what the stock is really worth.
View ValuationCompare EMBC vs DBVT
Side-by-side business, growth, and profitability comparison vs DBV Technologies S.A..
Start ComparisonEMBC — Frequently Asked Questions
Quick answers to the most common questions about buying EMBC stock.
What is the EMBC stock price target for 2026?
The consensus Wall Street price target for EMBC is $12, representing 233.3% upside from the current price of $3.6. With 4 analysts covering the stock, this strong upside suggests significant value not yet reflected in today's share price.
Is EMBC a buy, sell, or hold?
EMBC has a consensus rating of "Sell" based on 4 Wall Street analysts. The rating breakdown is leaning bearish, with 2 Sell/Strong Sell ratings. The consensus 12-month price target of $12 implies 233.3% upside from current levels.
Is EMBC stock overvalued or undervalued?
With a forward P/E of 1.2789x, EMBC trades at a relatively low valuation. The consensus target of $12 implies 233.3% appreciation, suggesting meaningful undervaluation.
How high can EMBC stock go?
The most bullish Wall Street analyst has a price target of $12 for EMBC, while the most conservative target is $12. The consensus of $12 represents the median expectation. These targets typically reflect 12-month expectations.
How many analysts cover EMBC stock?
EMBC is lightly followed, with 4 analysts providing price targets and ratings. Of these, 0 have Strong Buy ratings, 1 have Buy ratings, 1 recommend Hold, and 2 have Sell or Strong Sell ratings. Higher analyst coverage generally indicates greater institutional interest and more reliable consensus estimates.
What is the EMBC stock forecast?
The 12-month EMBC stock forecast based on 4 Wall Street analysts shows a consensus price target of $12, with estimates ranging from $12 (bear case) to $12 (bull case). The median consensus rating is "Sell".
What is EMBC's forward P/E ratio?
EMBC trades at a forward P/E ratio of 1.3x based on next-twelve-months earnings estimates compared to a trailing P/E of 2.2x. The lower forward P/E indicates analysts expect earnings growth. A forward P/E is useful for comparing valuations when earnings are expected to change significantly.
Should I buy EMBC stock?
Wall Street analysts are very optimistic on EMBC, with a "Sell" consensus rating and $12 price target (233.3% upside). 1 of 4 analysts rate it Buy or Strong Buy. This information is for educational purposes only. Always conduct your own research, consider your financial situation, and consult a financial advisor before making investment decisions.
Why do EMBC price targets vary so much?
EMBC analyst price targets range from $12 to $12, a 0% tight range reflecting strong analyst consensus. Differences stem from varying assumptions about revenue growth, profit margins, competitive dynamics, and valuation multiples. The $12 consensus represents the middle ground.